Difference of osteopontin gene regulation between bone and kidney

Journal of Orthopaedic Science

Volumn 8, Issue 3, 2003, Pages 361-366

  Sakuma, Takahiko ^a   Higashibata, Yuji ^a   Kawahata, Hirohisa ^a   Yamada, Shuichi ^b   Okabe, Masaru ^b   Kitamura, Yukihiko ^a   Nomura, Shintaro ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

In situ hybridization; Osteopontin; Promoter; Transgenic mouse; Galactosidase

Indexed keywords

BETA GALACTOSIDASE; GENE PRODUCT; OSTEOPONTIN;

ANIMAL TISSUE; ARTICLE; BONE; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; IN SITU HYBRIDIZATION; KIDNEY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN LOCALIZATION; REPORTER GENE; SOUTHERN BLOTTING; TISSUE DIFFERENTIATION; TRANSGENIC MOUSE;

EID: 0038120872     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10776-002-0627-2     Document Type: Article

References (29)

1. Asplin JR, Arsenault D, Parks JH, et al. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 1998;53:194-9.
2. Craig AM, Smith JH, Denhardt DT. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J Biol Chem 1989;264:9682-9.
3. Franzén A, Heinegård D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 1985;232:715-24.
4. Guo H, Cai CQ, Schroeder RA, et al. Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol 2001;166:1079-86.
5. Hijiya N, Setoguchi M, Matsuura K, et al. Cloning and characterization of the human osteopontin gene and its promoter. Biochem J 1994;303:255-62.
6. Hirakawa K, Hirota S, Ikeda T, et al. Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization. J Bone Miner Res 1994;9:1551-7.
7. Ikeda T, Yamaguchi A, Yokose S, et al. Changes in biological activity of bone cells in ovariectomized rats revealed by in situ hybridization. J Bone Miner Res 1996;11:780-8.
8. Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991;15:175-92.
9. Kelly DJ, Wilkinson-Berka JL, Ricardo SD, et al. Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Nephrol Dial Transplant 2002;17:985-91.
10. Kohri K, Nomura S, Kitamura Y, et al. Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 1993;268:15180-4.
11. Min W, Shiraga H, Chalko C, et al. Quantitative studies of human urinary excretion of uropontin. Kidney Int 1998;53:189-93.
12. Nagasawa Y, Takenaka M, Kaimori J, et al. Rapid and diverse changes of gene expression in the kidney of protein-overload proteinuria mice detected by microarray analysis. Nephrol Dial Transplant 2001;16:923-31.
13. Nomura S, Wills AJ, Edwards DR, et al. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 1988;106:441-50.
14. Nomura S, Hirakawa K, Nagoshi J, et al. Method for detecting the expression of bone matrix protein by in situ hybridization using decalcified mineralized tissues. Acta Histochem Cytochem 1993; 26:303-9.
15. Okabe M, Ikawa M, Kominami K, et al. "Green mice" as a source of ubiquitous green cells. FEBS Lett 1997;407:313-9.
16. Panzer U, Thaiss F, Zahner G, et al. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 2001; 59:1762-9.
17. Patarca R, Freeman GJ, Singh RP, et al. Structural and functional studies of the early T lymphocyte activation 1 (Eat 1) gene. J Exp Med 1989;170:145-61.
18. Peason B, Wolf PI, Vazquez J. A comparative study of a series of new indolyl compounds to localize β-galactosidase in tissues. Lab Invest 1963;12:1249-59.
19. Ray PE, Suga S, Liu X-H, et al. Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats. Kidney Int 2001;59:1850-8.
20. Sato M, Morii E, Komori T, et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2α/CBFA1 and ETS1 in the skeletal tissues. Oncogene 1998;17:1517-25.
21. Sato M, Yasui N, Nakase T, et al. Expression of bone matrix proteins mRNA during distraction osteogenesis. J Bone Miner Res 1998;13:1221-31.
22. Terai K, Takano-Yamamoto T, Ohba Y, et al. Role of osteopontin in bone remodeling caused by mechanical stress. J Bone Miner Res 1999;14:839-49.
23. Verhulst A, Persy VP, van Rompay AR, et al. Osteopontin synthesis and localization along the human nephron. J Am Soc Nephrol 2002;13:1210-8.
24. Verstrepen WA, Persy VP, Verhulst A, et al. Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat. Nephrol Dial Transplant 2001;16:712-24.
25. Wang D, Yamamoto S, Hijiya N, et al. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene 2000;19:5801-9.
26. Weiss DJ, Liggitt D, Clark JG. In situ histochemical detection of β-galactosidase activity in lung: assessment of X-Gal reagent in distinguishing lacZ gene expression and endogenous βgalactosidase activity. Hum Gene Ther 1997;8:1545-54.
27. Yamate T, Kohri K, Umekawa T, et al. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell. J Urol 1989;160:1506-12.
28. Yoshitake H, Rittling SR, Denhardt DT, et al. Osteopontindeficient mice arc resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 1999;96:8156-60.
29. Xie Y, Nishi S, Iguchi S, et al. Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process. Kidney Int 2001;59:959-74.